Our research explores the connection between time-in-range and mental health in people with type 1 and type 2 diabetes.
Our research reveals low awareness of DKA and ketone testing among type 2 diabetes patients on SGLT2 inhibitors, highlighting urgent education needs.
For over 12 years, dQ&A has gathered primary data from diabetes healthcare practitioners (HCPs)—notably endocrinologists and primary care physicians—expanding our ‘Prescriber Perspectives’ tracker to five countries with insights from key prescribers and influencers.